Losartan attenuates paraquat-induced pulmonary fibrosis in rats
Authors:
- 17 September 2014
- journal article
- Published by SAGE Publications in Human & Experimental Toxicology
- Vol. 34 (5) , 497-505
Abstract
Paraquat (PQ) is one of the most widely used herbicides in the world and can cause pulmonary fibrosis in the cases with intoxication. Losartan, an angiotensin II type 1 receptor antagonist, has beneficial effects on the treatment of fibrosis. The aim of this study was to examine the effect of losartan on pulmonary fibrosis in PQ-intoxicated rats. Adult male Sprague Dawley rats ( n = 32, 180–220 g) were randomly assigned to four groups: (i) control group; (ii) PQ group; (iii) PQ + losartan 7d group; and (iv) PQ + losartan 14d group. Losartan treatment (intragastrically (i.g.), 10 mg/kg) was performed for 7 and 14 days after a single i.g. dose of 40 mg/kg PQ. All rats were killed on the 16th day, and hematoxylin–eosin and Masson’s trichrome staining were used to examine lung injury and fibrosis. The levels of hydroxyproline and transforming growth factor β1 (TGF-β1), matrix metallopeptidase 9 (Mmp9), and tissue inhibitor of metalloproteinase 1 (TIMP-1) messenger RNA (mRNA) expression and relative expression levels of collagen type I and III were also detected. PQ caused a significant increase in hydroxyproline content, mRNA expression of TGF-β1, Mmp9, and TIMP-1, and relative expression levels of collagen type I and III ( p < 0.05), while losartan significantly decreased the amount of hydroxyproline and downregulated TGF-β1, Mmp9, and TIMP-1 mRNA and collagen type I and III expressions ( p < 0.05). Histological examination of PQ-treated rats showed lung injury and widespread inflammatory cell infiltration in the alveolar space and pulmonary fibrosis, while losartan could markedly reduce such damage and prevent pulmonary fibrosis. The results of this study indicated that losartan could reduce lung damage and prevent pulmonary fibrosis induced by PQ.Keywords
This publication has 34 references indexed in Scilit:
- Angiotensin signalling in pulmonary fibrosisThe International Journal of Biochemistry & Cell Biology, 2012
- Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in ratArchives of Biochemistry and Biophysics, 2009
- An antisense oligonucleotide to HSP47 inhibits paraquat-induced pulmonary fibrosis in ratsToxicology, 2007
- Mouse model of paraquat-poisoned lungs and its gene expression profileToxicology, 2007
- Gene expression of cytokines and growth factors in the lungs after paraquat administration in miceLegal Medicine, 2006
- Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: Potential implications in asthma and other lung diseasesEuropean Journal of Pharmacology, 2006
- Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heartJournal of Laboratory and Clinical Medicine, 2004
- Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activityInflammation Research, 2001
- Antioxidant properties of ambroxolFree Radical Biology and Medicine, 1994
- Protective effect of liposome-associated α-tocopherol against paraquat-induced acute lung toxicityBiochemical Pharmacology, 1992